Dupilumab Treats Itch and Clears Lesions in Prurigo Nodularis Patients Dupilumab Treats Itch and Clears Lesions in Prurigo Nodularis Patients

Nearly 60% of patients with prurigo nodularis (PN) who received dupilumab reported a significant reduction in itching after 24 weeks of treatment.Medscape Medical News

Source: Medscape Dermatology Headlines - March 31, 2022 Category: Dermatology Tags: Dermatology News Source Type: news